Table 2.
Group | Dose (mg/kg body weight/day) | Triglycerides (mg/dL) | Total cholesterol (mg/dL) | NEFA (mEq/L) | HDL-C (mg/dL) | LDL/VLDL-C (mg/dL) | |
---|---|---|---|---|---|---|---|
m/m | — | 114 ± 9c | 110 ± 8c | 0.62 ± 0.02c | 51.01 ± 3.55c | 522 ± 4b | |
db/db | |||||||
Veh | — | 263 ± 21 | 186 ± 8 | 2.55 ± 0.06 | 80.95 ± 2.49 | 570 ± 17 | |
GS | 20 | 198 ± 16a | 179 ± 14 | 1.98 ± 0.04c | 90.88 ± 7.68 | 394 ± 21a | |
GS | 100 | 175 ± 8b | 163 ± 11 | 1.56 ± 0.15c | 95.88 ± 3.16b | 355 ± 13c | |
| |||||||
Group | Dose (mg/kg body weight/day) | ROS (fluorescence/min/mL) | TBARS (nmol/mL) | Adiponectin (ng/mL) | Resistin (pg/mL) | TNF-α (pg/mL) | IL-6 (pg/mL) |
| |||||||
m/m | — | 790 ± 175a | 18.33 ± 0.46c | 6.32 ± 0.27c | 522 ± 4b | 117 ± 17a | 11.08 ± 0.33c |
db/db | |||||||
Veh | — | 1,563 ± 144 | 22.48 ± 0.51 | 3.18 ± 0.09 | 570 ± 17 | 261 ± 28 | 21.27 ± 2.07 |
GS | 20 | 950 ± 112a | 11.88 ± 1.45 | 3.68 ± 0.12b | 394 ± 21c | 162 ± 30a | 14.90 ± 2.07 |
GS | 100 | 840 ± 70b | 9.06 ± 1.19c | 4.63 ± 0.19c | 355 ± 13c | 133 ± 13b | 12.45 ± 1.19b |
m/m, Misty; Veh, vehicle-treated db/db mice; GS20, GS20 mg/kg body weight-treated db/db mice; GS100, GS100 mg/kg body weight-treated db/db mice. The results are presented as the means ± S.E.M. a P < 0.05, b P < 0.01, c P < 0.001 versus vehicle-treated db/db mouse values.